# STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)

> **NCT07122661** · — · ACTIVE_NOT_RECRUITING · sponsor: **Pfizer** · enrollment: 1 (estimated)

## Conditions studied

- Respiratory Syncytial Virus (RSV)
- Respiratory Syncytial Virus
- Lower Respiratory Tract Disease
- Respiratory Tract Diseases
- Acute Respiratory Illness (ARI)

## Interventions

- **BIOLOGICAL:** ABRYSVO

## Key facts

- **NCT ID:** NCT07122661
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-08-11
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-04-30
- **Target enrollment:** 1 (ESTIMATED)
- **Last updated:** 2025-11-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07122661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07122661, "STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07122661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*